Bruce Baron

The FDA has cleared marketing of the Kronus Zinc Transporter 8 Autoantibody test for type 1 diabetes.

Controversy about the effects of subclinical thyroid dysfunction and bone health are further clouded by conflicting study results.

FDA has granted Basaglar (insulin glargine) tentative approval for treatment of type 1 and type 2 diabetes.